Gausman, O'Day, Schoop Join Orioles' Departure

NEW YORK (AP) — Pitchers Kevin Gausman and Darren O'Day and infielder Jonathan Schoop joined the exodus from the Baltimore Orioles, who have cut nearly $29 million in payroll obligations for this year and next while acquiring 14 prospects, one major leaguer and $2.75 million in international signing bonus allotment in exchange for six veterans.

The Orioles obtained $2.5 million in allotment from Atlanta on Tuesday for the pitchers and also got four prospects: right-hander Evan Phillips, infielder Jean Carlos Encarnacion, catcher Brett Cumberland and left-hander Bruce Zimmerman. They acquired infielder Jonathan Villar along with a pair of minor leaguers from Milwaukee for Schoop, getting right-hander Luis Ortiz and infielder Jean Carmona.

Baltimore began the day a major league-worst 32-74. The Orioles began the sell-off on July 18 by sending Machado, a four-time All-Star, to the Los Angeles Dodgers for outfielder Yusniel Diaz, infielders Rylan Bannon and Breyvic Valera, and right-handers Dean Kremer and Zach Pop.

Six days later they dealt All-Star closer Zach Britton to the New York Yankees for right-handers Dillon Tate and Cody Carroll, and left-hander Josh Rogers. And on Sunday they traded reliever Brad Brach to the Braves for $250,000 of allotment.

The Orioles cut this year's payroll by $20,077,929 with the deals of the six plus $9 million from 2019, and added $836,290 for this year with Villar. The Orioles started with a $151 million payroll for their 40-man roster.

Machado's departure saved $6,365,591 from his $16 million salary, Britton's $4,387,097 from his $12 million, Brach's $1,749,435 from his $5,165,000, Gausman's $1,836,559 from his $5.6 million, O'Day's $2,951,613 of his $9 million and Schoop's $2,787,634 of his $8.5 million. Schoop also has a guaranteed $9 million salary for next year.

Villar is owed $836,290 from his $2.55 million salary

Follow @WJZ on Twitter and like WJZ-TV | CBS Baltimore on Facebook

(© Copyright 2018 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.